[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-342969-105":59,"doc-detail-342969-en":122},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":115,"head_meta":117,"extra_data":119,"updated_unix":121},105,"en","an-increase-of-serum-ca-125-to-two-times-of-nadir-level-strongly-predicts-the-image-identified-relapse-of-serous-ovarian-cancer","An increase of serum CA-125 to two times of nadir level strongly predicts the image-identified relapse of serous ovarian cancer","","This study evaluates whether a biochemical relapse defined by CA125 elevation can accurately predict an image-identified relapse in patients with stage I–IV serous ovarian, tubal, and peritoneal cancers. Data from 162 complete clinical responders (Jan 2013–Jun 2019) examine CA125 thresholds, showing that CA125 reaching 2× nadir predicts image-identified relapse with higher sensitivity and earlier warning time than a 35 U/mL cutoff. The CA125 trend after initial therapy is compared between NACT and PDS groups.",{"@graph":69,"@context":114},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/an-increase-of-serum-ca-125-to-two-times-of-nadir-level-strongly-predicts-the-image-identified-relapse-of-serous-ovarian-cancer/342969/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/an-increase-of-serum-ca-125-to-two-times-of-nadir-level-strongly-predicts-the-image-identified-relapse-of-serous-ovarian-cancer/342969.png","ImageObject",300,407,{"name":92,"@type":93},"Noah","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108],{"name":109,"@type":110,"acceptedAnswer":111},"Does treatment strategy (NACT vs PDS) affect CA125 trends after initial therapy?","Question",{"text":112,"@type":113},"Among relapsed patients, there was no difference in CA125 changing trends between the neoadjuvant chemotherapy (NACT) and primary debulking surgery (PDS) groups after initial treatment.","Answer","https://schema.org",{"og:url":83,"og:type":116,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":118,"canonical":83},"index,follow",{"doc_id":120,"site_id":62},342969,1790386553,{"code":4,"msg":5,"data":123},{"doc_id":120,"user_id":124,"nickname":92,"user_avatar":125,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":126,"file_id":127,"file_url":128,"file_type":129,"file_size":130,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":131,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":132,"faqs":133,"seo_title":134,"seo_description":67,"update_tm":135,"read_time":136,"preview_page_count":19,"preview_urls":137},8796095462418,"https://ap-avatar.wpscdn.com/avatar/80000253c1241d02b47?x-image-process=image/resize,m_fixed,w_180,h_180&k=1778826106357471780","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nAn increase of serum CA‑125 to two times of nadir level strongly predicts the image‑identified relapse of serous ovarian cancer  \nKaiwen Du1, Qian Li1, Jin Huang2,3, David Wai Chan4, Jinjin Li1, Xiaoxia Chang1, Hanjie Wang1, Junying Tang1* & Qiyu Yang1*  \nUsing 70 U/ml or 35 U/ml as CA125 routine abnormal threshold may result in omissions in the relapse detection of Ovarian cancer (OvCa). This study aimed to clarify the association between a biochemical relapse (only the elevation of CA125) and an image‑identified relapse to predict the relapsed lesions better. 162 patients who achieved complete clinical response were enrolled from women diagnosed with stage I‑IV serous ovarian, tubal, and peritoneal cancers from January 2013 to June 2019 at our center. The CA125 level of 2 × nadir was defined as the indicator of image‑identified relapse (P \u003C 0.001) . Compared to CA125 level exceeding 35 U/ml, the 2 × nadir of CA125 improve the sensitivity of image‑ identified relapse (84.9% vs 67.4%, P \u003C 0.001); the 2 × nadir value can act as an earlier warning relapse signal with a longer median time to image‑identified relapse (2.7 vs. 0 months, P \u003C 0.001) . Of therelapsed population, there was no difference of CA125 changing trend between the neoadjuvant chemotherapy (NACT) and primary debulking surgery (PDS) group after initial treatment. Compared with 35 U/ml, CA125 reaching 2 × nadir during the follow‑up process might be a more sensitive and early relapse signal in patients with serous OvCa. This criterion may help guide patients to be recommended for imaging examination to detect potential relapse in time.  \nAbbreviations  \nCA125 Cancer antigen 125 OvCa Ovarian cancer  \nEOC Epithelial ovarian cancer NACT Neoadjuvant chemotherapy IDS Interval debulking surgery PDS Primary debulking surgery  \nFIGO International federation of gynecology and obstetrics RT Residual tumor  \nOvarian cancer is the second deadliest gynecological cancer, with a 5-year survival rate of 50.8%1. Over 80% of these women are diagnosed as serous epithelial tissue2. The standard treatment involves cytoreduction surgery and chemotherapy. Primary debulking surgery (PDS) followed by platinum-based chemotherapy is the preferred initial treatment for advanced-stage ovarian cancer. Neoadjuvant chemotherapy (NACT) followed by interval debulking surgery (IDS) is an alternative option for those who cannot undergo PDS. While many randomized clinical trials have shown the non-inferiority of NACT in survival outcomes3,4, a recent study found that women in the NACT group experienced more relapses in the pelvis or upper abdomen compared to the PDS group5. Regardless of the treatment option, complete resection of the tumor through surgery remains crucial in reducing the relapse rate and improving survival.  \n1Department of Obstetrics and Gynecology, The First Affiliated Hospital of Chongqing Medical University, No.1 Youyi Road, Yuzhong District, Chong Qing 400000, People’s Republic of China. 2Department of Obstetrics and Gynecology, The Second Affiliated Hospital, The Chinese University of Hong Kong-Shenzhen, Shenzhen, People’s Republic of China. 3Department of Obstetrics and Gynecology, The Chinese University of Hong Kong, Hong Kong SAR, People’s Republic of China. 4School of Medicine, The Chinese University of Hong Kong-Shenzhen, Shenzhen,  \nPeople’s Republic of China.*[email: tangjy_cqmu@sina.com](email: tangjy_cqmu@sina.com); [yangqy_cqmu@qq.com](yangqy_cqmu@qq.com)  \n[www. nature.com/scientificreports/](www. nature.com/scientificreports/)  \nOvarian cancer recurs in 25% of early-stage and more than 80% of advanced-stage women6. Effective followup tests are needed to detect relapse or disease progression. Screening methods include physical examination, serum tumor biomarkers, and imaging techniques. The most widely used tumor biomarker is CA125, a glycoprotein found on the surface of ovarian cancer cel","cbCair8YtmyeudNx","https://ap.wps.com/l/cbCair8YtmyeudNx","pdf",1135562,"English","# Study background and clinical need\n## CA125 thresholds and relapse detection\n# Methods and study population\n## Patient selection and follow-up approach\n# Results and predictive performance\n## Sensitivity and median time to relapse\n# Clinical implications\n## Guidance for imaging and monitoring","[{\"question\":\"Does treatment strategy (NACT vs PDS) affect CA125 trends after initial therapy?\",\"answer\":\"Among relapsed patients, there was no difference in CA125 changing trends between the neoadjuvant chemotherapy (NACT) and primary debulking surgery (PDS) groups after initial treatment.\"}]","An increase of serum CA-125 to two times of nadir level strongly predicts the image-identified relapse of serous ovarian cancer | PDF",1790049180,25,[138,142,146,150],{"page_no":8,"url":139,"width":140,"height":141},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4649a29a6334888c0148248c1fdcdef7.webp",983,1291,{"page_no":14,"url":143,"width":144,"height":145},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/02e27b6e4a357b501e2540137d1bc428.webp",982,1290,{"page_no":81,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/81603851c2365bbc6dc57ae50169d373.webp",981,1289,{"page_no":19,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/44f7d8cfda062b0ae63ab17cee7d0023.webp",980,1287]